chief medical officer

Board room C-suite meeting contract
Biotech

Dyne shakes up C-suite after hazy DMD data drop

Dyne Therapeutics has revealed new phase 1/2 data on its Duchenne muscular dystrophy therapy DYNE-251, including several serious TEAEs.
Fraiser Kansteiner Sep 3, 2024 11:49am
pink lotus pond lotus flower

CRO Lotus' founder leaps to Latigo

Aug 20, 2024 1:59pm
Pi Day Cherry and Apple Pies - making homemade traditional various Pies with Pi sign for March 14th holiday on white wooden

Oncology CRO taps biotech leader as new CMO

Aug 13, 2024 2:05pm
Greek letters alphabet ancient ruins

Rho names NYU neurologist Andrew Feigin new CMO

Aug 6, 2024 3:10pm
Graphic of an open door with the words exit above it

CRISPR Tx CMO resigns just 6 days after Casgevy's FDA approval

Dec 20, 2023 12:00pm
quit fire layoff workforce reduction exit

Kodiak's CMO hands in notice a month after pair of phase 3 fails

Aug 18, 2023 7:35am